Where the needle goes is seen, not estimated.
Intra-articular and soft-tissue injections placed under ultrasound, plus trigger-point injection and dry needling for myofascial pain. The point of the ultrasound is not the technology — it is that the drug reaches the space it was prescribed for, and that any fluid there is seen before anything is injected.
You don't need a diagnosis to start — the board reads your records and answers in writing. These are the situations that usually bring people to this page.
The injection is never the plan on its own — it is booked as the step that makes the programme possible, and the programme is written before the needle.
If your question isn't here, ask it directly — a human replies in minutes, in 8 languages.
Because placement can be confirmed rather than assumed. In a randomised trial across 148 painful joints, sonographic guidance reduced procedural pain by 43% and pain at two weeks by 59%, and raised the responder rate by 26% (Sibbitt et al., The Journal of Rheumatology, 2009).
That is answered after the first one, by what changes. A plan that commits you to a course of injections before seeing the response is selling a course, not treating a joint.
You leave with a written home programme, and your therapist reviews you on protected video calls on a fixed rhythm. The numbers keep being collected.
Nothing. The board's first review is free, and your programme — sessions, reviews, home plan — is quoted fixed and in writing before it starts.
Most cases cross institutes. These often travel together — and the board reads them as one case.
Send what you have — scans, letters, or just the story so far. A senior consultant first-reads within 24 hours; the board answers in writing within 72 hours of your records being complete — free, before you commit to anything.